Ignite Creation Date:
2024-05-06 @ 8:08 PM
Last Modification Date:
2025-12-16 @ 11:13 PM
Study NCT ID:
NCT06264180
Status:
None
Last Update Posted:
2025-09-22 00:00:00
First Post:
2024-01-29 00:00:00
Brief Title:
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
Sponsor:
Organization:
Replimune Inc.
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
400
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE3 |
Observational Models:
Time Perspective List:
Who Masked List: